Cardiff Oncology, Inc. ( CRDF) - Key Metrics
CRDF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.13 | -$0.17 | -$0.17 |
| 2026Q1 | $0 | -$0.18 | -$0.18 | -$0.18 |
| 2025Q4 | $0 | -$0.11 | -$0.09 | -$0.09 |
| 2025Q3 | $0 | -$0.17 | -$0.16 | -$0.16 |
| 2025Q2 | $0 | -$0.21 | -$0.13 | -$0.13 |
CRDF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.32 |
| 2026Q1 | 0% | -2.25 |
| 2025Q4 | 0% | -6.39 |
| 2025Q3 | 0% | -3.03 |
| 2025Q2 | 0% | -3.75 |
CRDF
Price: $0.97
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.57 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 531000
Market Capitalization: 87.9 million